Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01437241
What this trial is testing

Etravirine Plus 2 Analogs in HIV-infected Patients

Who this might be right for
HIV-1-infection
Hospitales Universitarios Virgen del Rocío 175
Large-scale testing (Phase 3)UnknownNCT04406727
What this trial is testing

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Who this might be right for
HIV-1 Infection
United BioPharma 50
Testing effectiveness (Phase 2)Study completedNCT00000823
What this trial is testing

Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Not applicableStudy completedNCT04002323
What this trial is testing

Real Life Study of Dolutegravir Plus Lamivudine in HIV-1-Infected Treatment-Naive Patients

Who this might be right for
HIV-1-infection
University Hospital Virgen de las Nieves 88
Early research (Phase 1)Study completedNCT02362217
What this trial is testing

Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination

Who this might be right for
Hepatitis C InfectionHIV Infection
University of Oxford 33
Not applicableStudy completedNCT00636220
What this trial is testing

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

Who this might be right for
HIV Infections
Chembio Diagnostic Systems, Inc. 101
Post-approval studies (Phase 4)Study completedNCT03052010
What this trial is testing

The Partners Scale-Up Project

Who this might be right for
HIV-1-infection
University of Washington 4,898
Post-approval studies (Phase 4)UnknownNCT05147740
What this trial is testing

Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age

Who this might be right for
HIV-1-infection
Tulika Singh, MD 50
Early research (Phase 1)Study completedNCT02756208
What this trial is testing

A Safety and Immunogenicity Trial of IHV01

Who this might be right for
HIV Infection
University of Maryland, Baltimore 65
Post-approval studies (Phase 4)Study completedNCT01772940
What this trial is testing

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Who this might be right for
HIV-1 Infection
Centre Hospitalier Universitaire Saint Pierre 425
Testing effectiveness (Phase 2)Study completedNCT00002210
What this trial is testing

Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Who this might be right for
HIV Infections
Pharmacia and Upjohn 24
Not applicableUnknownNCT02674867
What this trial is testing

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 80
Early research (Phase 1)WithdrawnNCT00000809
What this trial is testing

Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableLooking for participantsNCT03603977
What this trial is testing

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 600
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Post-approval studies (Phase 4)Study completedNCT02042001
What this trial is testing

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Who this might be right for
Impaired CognitionDepression/AnxietyPoor Quality Sleep+2 more
Azienda Ospedaliera San Gerardo di Monza 74
Not applicableStudy completedNCT04711265
What this trial is testing

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Who this might be right for
HPV VaccineHPV InfectionHIV-1-infection
Kenya Medical Research Institute 176
Large-scale testing (Phase 3)Study completedNCT01453192
What this trial is testing

Renal Transplantation and Raltegravir in HIV-Infected Patients

Who this might be right for
HIV-1 InfectionChronic Renal Insufficiency
ANRS, Emerging Infectious Diseases 27
Testing effectiveness (Phase 2)Ended earlyNCT02566707
What this trial is testing

Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance Regimen

Who this might be right for
HIV-1 Infection
Radboud University Medical Center 9
Early research (Phase 1)Active Not RecruitingNCT06919016
What this trial is testing

Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 45
Next Page